Markets › Super Investors › BANDHAN BALANCED ADVANTAGE FUND
BF
BANDHAN BALANCED ADVANTAGE FUND
Mutual FundDisclosed Indian equity holdings above the 1% filing threshold.
Disclosed value
₹1,417 Cr
Today
+₹13.3 Cr +0.95%
Companies
3
As of
31 Mar 2026
Returns vs NIFTY current basket, 1 year
This portfolio -3.1% NIFTY 50 -4.4%ahead of NIFTY by 1.3 pts
Today’s disclosed holdings valued back over the past year vs the NIFTY 50, rebased to 0%. Not a record of actual trades.
Sector allocation
Portfolio X-ray
Top-5 weight
100%
Wtd P/E
25.7
Wtd ROE
26.2%
Holdings
3
By market cap
Large 99% Mid 0% Small 1%
Sold / trimmed last quarter
Suraksha Diagnostic Ltd0.00pp
Holdings · 3
| Company▾ | Stake▾ | Value▼ | Today▾ | Q/Q▾ | P/E▾ | ROE▾ |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd GLENMARK · Healthcare | 1.17% | ₹713.4 Cr | -0.79% | NEW | 44.7 | 14% |
| Cholamandalam Financial Holdings Ltd CHOLAHLDNG · Financial Services | 2.33% | ₹685.2 Cr | +2.85% | NEW | 5.4 | 39% |
| Suraksha Diagnostic Ltd SURAKSHA · Healthcare | 1.32% | ₹18.5 Cr | +0.07% | ▼ 0.00pp | 44.5 | 14% |
Stake history by quarter (%) increased trimmed
| Company | Mar '26 | Dec '25 | Sept '25 | Jun '25 |
|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd | 1.17 | · | · | · |
| Cholamandalam Financial Holdings Ltd | 2.33 | · | · | · |
| Suraksha Diagnostic Ltd | 1.32 | 1.32 | 1.32 | 1.33 |
Holdings are taken exactly as filed in public shareholding disclosures, shown only once a stake crosses the 1% disclosure threshold, so this is the holder’s large positions, not every holding. Value = disclosed shares × latest market price, so it moves daily while share counts update each quarter; “Q/Q” compares with the prior filing (pp = percentage points). Names are shown as filed and folded only for capitalisation and spacing, never different spellings; a common name could, in principle, represent more than one person. For information only, not investment advice.